Motus GI Holdings found using ticker (MOTS) now have 6 analysts in total covering the stock. The consensus rating is ‘Strong_Buy’. The target price ranges between 3 and 2 calculating the mean target price we have 2.5. With the stocks previous close at 0.97 this indicates there is a potential upside of 157.7%. The day 50 moving average is 0.9 and the 200 day MA is 1.05. The company has a market cap of $32m. Company Website: http://www.motusgi.com
Motus GI Holdings, a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company is based in Fort Lauderdale, Florida.